Golden State Equity Partners Amerisourcebergen Corp Transaction History

Golden State Equity Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	N/A	-3,583 Reduced 71.23%	1,447 $267,000
Q2 2024 Jul 29, 2024	SELL	N/A	-344 Reduced 6.4%	5,030 $931,000
Q4 2023 Feb 02, 2024	SELL	$179.08 - $189.89 $25,787 - $27,344	-144 Reduced 2.61%	5,374 $994,000
Q3 2023 Oct 20, 2023	BUY	$172.87 - $193.41 $681,972 - $763,002	3,945 Added 250.79%	5,518 $993,000
Q2 2023 Jul 19, 2023	SELL	$162.28 - $192.43 $26,289 - $31,173	-162 Reduced 9.34%	1,573 $302,000
Q1 2023 Jun 01, 2023	BUY	$148.37 - $168.96 $257,421 - $293,145	1,735 New	1,735 $278 Million

1,261

168M

7.52M

6.12M

Ticker ABC
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 207,258,000
Market Cap $38.4B
Description
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, inc...

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

Stay updated on Golden State Equity Partners with notifications on news.